Gelonghui, December 12th丨Autobio Diagnostics (603658.SH) announced that as of December 12, 2024, the term of the shareholding plan implemented by Mr. Miao Yongjun, Chairman and actual controller, has expired. Mr. Miao Yongjun has cumulatively increased his shareholding in the company by 452,800 shares through the centralized bidding trading system of the Shanghai Stock Exchange, accounting for 0.0779% of the company's total share capital, with a cumulative investment amount of 21,021,355 yuan. This shareholding plan has been completed.
安图生物(603658.SH)：董事长、实际控制人苗拥军累计完成增持约2100万元公司股份
Autobio Diagnostics (603658.SH): The Chairman and actual controller, Miao Yongjun, has cumulatively completed a Shareholding of approximately 21 million yuan of the company's shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated